Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants. - Wikidata - awgldk - TriplyDB

Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.

Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.

http://www.wikidata.org/entity/Q44058392

about

A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Counselling framework for moderate-penetrance cancer-susceptibility mutations.Identification of six new susceptibility loci for invasive epithelial ovarian cancer.A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene.

P2860

Q27302763-DEDF0B50-736B-499F-ABD6-3F1695B46910 Q28266112-A42BFDAE-7948-45D0-88F6-3132A0FC5E76 Q30252854-AA97F387-91FB-4DF4-8971-1CF112BC8C65 Q33911135-F7FDE9DA-B460-4C70-8AA4-0AC838E25CB4 Q35541663-8ED42BCC-5A75-433A-9D1B-8A5D38675795 Q35848518-FD3CF39A-F320-45B0-BA47-48521E10201E Q36087170-696E0E3B-5F18-4753-B762-29F61AFE492A Q36276527-405404AF-412E-4F36-B734-AC5CFBF92C64 Q38614203-D4AFA1C2-7227-4DBE-B6DA-7758EACD51C0 Q40053289-0F55A4D4-DC68-46CB-9A29-9FC2AB97CA94

P2860

Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.

http://www.wikidata.org/entity/Q44058392

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Ovarian cancer familial relati ...... netic susceptibility variants.

@en

Ovarian cancer familial relati ...... netic susceptibility variants.

@nl

type

label

Ovarian cancer familial relati ...... netic susceptibility variants.

@en

Ovarian cancer familial relati ...... netic susceptibility variants.

@nl

prefLabel

Ovarian cancer familial relati ...... netic susceptibility variants.

@en

Ovarian cancer familial relati ...... netic susceptibility variants.

@nl

P1433

Q44058392-879B6037-113B-43F2-9905-470726F5CE98

P1476

Q44058392-E6472B9A-6ABE-4BC8-85C0-3F00ADDC25CD

P2093

Q44058392-23FE58A5-24AD-4926-A4C6-F171B3BE65FF

Q44058392-3E327481-7787-4B3A-A7D9-471A5000601E

Q44058392-4F840253-5F29-4C3E-99AC-3BBE4FEDFD32

Q44058392-5C82D872-663D-4FE5-B245-3F98631C5BB4

Q44058392-B2EB21AF-C29B-48B8-89AA-681B5FE34763

Q44058392-BD9B2604-7A9A-4055-AAAB-002BB3B96CB1

Q44058392-D0AC6B6E-D5F7-458C-A876-88E4C342F537

Q44058392-F78B1B56-8878-4E57-A48C-326D910B3B1A

P2860

Q44058392-1780DB64-72DC-470F-AC58-134D8D6FE8DA

Q44058392-248AE2BF-5FA6-48B8-AD31-4159F208F83D

Q44058392-37D2AD4C-CC82-44B3-B538-0A21CB5FC8E6

Q44058392-3F93F6D3-3C35-4DEF-8A19-E02A5BCB7B65

Q44058392-3FB29146-1D1B-4E89-B954-1FC5D44E00BE

Q44058392-4C7E8026-49C9-4AE7-A535-E512835A1830

Q44058392-55F7EE6E-E2C1-44DA-8215-6058225D0F2C

Q44058392-5A605C65-6010-472F-99DD-6B76B9B5B4ED

Q44058392-5B31C61E-A1F5-4E7E-AAF2-DADF5F0B0FF1

Q44058392-5C1A15E4-74D9-49CD-A45E-A9175D2DC5FE

P304

Q44058392-6F179D95-144E-43F1-89FA-8686C21B767C

P31

Q44058392-43F7F045-63A3-4525-A655-66E3F502D6B8

P356

Q44058392-0A3F230D-172E-497A-B97F-87EDEDEBD79D

P407

Q44058392-D3607B24-BC8F-431E-8562-EA40459F7C73

P433

Q44058392-BD55BFB3-6BE5-4142-AB44-56440FFCAD07

P478

Q44058392-29B9BCCD-A78E-4ACE-B4FF-DE1CBBE66219

P50

Q44058392-03A4E736-B7C0-43C4-BB98-DFAC4FB551FD

Q44058392-AAD4EEB5-67A8-403E-BBC4-73A47E008675

P577

Q44058392-183DD436-F7E7-412C-9C5C-C56C77F0973A

P698

Q44058392-3BF92AF5-41A3-487E-9E2E-129A016BE8C5

P921

Q44058392-AF4D773D-0191-4072-B5B0-B414453FE486

P356

JMEDGENET-2013-102015

P1433

Journal of Medical Genetics

P1476

Ovarian cancer familial relati ...... netic susceptibility variants.

@en

P2093

Andrew Lee

http://www.w3.org/2001/XMLSchema#string

Ed Dicks

http://www.w3.org/2001/XMLSchema#string

Honglin Song

http://www.w3.org/2001/XMLSchema#string

Ian J Jacobs

http://www.w3.org/2001/XMLSchema#string

Jonathan Tyrer

http://www.w3.org/2001/XMLSchema#string

Patricia Harrington

http://www.w3.org/2001/XMLSchema#string

Paul P D Pharoah

http://www.w3.org/2001/XMLSchema#string

Sarah Jervis

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

RAD51C germline mutations in breast and ovarian cancer cases from high-risk families

Validation of family history data in cancer family registries.

Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer

Association between common variation in 120 candidate genes and breast cancer risk.

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.

The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

P304

108-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JMEDGENET-2013-102015

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Douglas F. Easton

Antonis C Antoniou

P577

2013-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24277755

http://www.w3.org/2001/XMLSchema#string

P921